Delivery Order SPE2DB20D2001-SPE2DB22FM35T
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,132.62, is for the delivery of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product. This order was issued under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., with a ceiling...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Azelastine 0.1% (137 mcg) Spray, 30 mL, with a firm fixed price of $1,547.25 and an ultimate completion date of September 13, 2024. The contract is not set aside for any small business designation. Amerisourcebergen, through its Corporate Office division, has been awarded this delivery order under a larger Indefinite...
- This federal contract award is for the delivery of Azelastine 0.1% (137 MCG) Nasal Spray, 30ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a firm fixed-price delivery order with a ceiling value of $3,585.39 and an ultimate completion date of December 22, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This contract award is for the delivery of Azelastine 0.1% (137 mcg) spray, 30 ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, and has a ceiling value of $1,415.26. The contract is structured as a Firm Fixed Price Delivery Order, with a period of performance through September 26, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,029.59 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) spray, a pharmaceutical product, with a completion date of November 8, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
- This contract award (SPE2DB20D2104|SPE2DB22FS22R) is for the delivery of Azelastine 0.1% (137 MCG) nasal spray, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,005.24 and a performance period ending on March 29, 2022. The contract was not set aside for any specific business...
- This is a $3,376.01 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Azelastine 0.1% (137 MCG) spray, a prescription medication, with a completion date of March 6, 2024. This delivery order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DB20D2001|SPE2DB23FM34M, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,084.96 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray in 30 mL containers. The contract has an ultimate completion date of January 4, 2023 and was awarded on January 3, 2023. There was no set-aside designation for this award. Amerisourcebergen Drug Corp, as a major...
- This federal contract award, with an ID of SPE2DB20D1109|SPE2DB22FQ05A, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,237.04 delivery order contract is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product, with a completion date of September 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
- This federal contract award, with ID SPE2DB20D7059|SPE2DB25FPTQ2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,322.40 firm fixed price delivery order is for the supply of 4566316369 - Azelastine 0.1% (137 MCG) Spray, 30 ML. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB22FM35TDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of azelastine 0.1% (137 mcg) nasal spray, a pharmaceutical product. The contract has a ceiling value of $1,144.56 and an ultimate completion date of January 6, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/5/22 |